Literature DB >> 6708592

High-resolution parathyroid ultrasonography in familial benign hypercalcemia (familial hypocalciuric hypercalcemia).

W M Law, E M James, J W Charboneau, D C Purnell, H Heath.   

Abstract

Familial benign hypercalcemia, or familial hypocalciuric hypercalcemia (FHH), is frequently confused with primary hyperparathyroidism, but the consistent failure of subtotal parathyroidectomy to normalize serum calcium levels in FHH makes accurate distinction from familial hyperparathyroidism imperative. Because ultrasonography frequently demonstrates enlargement of the parathyroid glands in hyperparathyroidism, we examined 14 hypercalcemic adults (who had not undergone operation) from seven kindreds with FHH by using a high-resolution real-time scanner. We compared our results with those from 156 patients (who had undergone scanning preoperatively) with surgically confirmed hyperparathyroidism. Enlargement of the parathyroid glands was detected ultrasonographically in 137 of 156 (88%) of the total group of patients with hyperparathyroidism and in 17 of 24 patients (71%) with hyperparathyroidism who had hypercalcemia (serum calcium, 10.6 to 11.0 mg/dl) comparable to that of the FHH group (mean value, 10.7 mg/dl). In contrast, the single possible parathyroid lesion seen in the FHH group was substantially smaller (4 mm) than the smallest (7 mm, 75 mg) abnormal gland reliably detected by ultrasonography in the group with hyperparathyroidism and was conceivably normal in size. Patients with FHH have a dramatic absence of ultrasonographic parathyroid enlargement. High-resolution parathyroid ultrasonography may be of ancillary diagnostic benefit in patients with familial hypercalcemia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6708592     DOI: 10.1016/s0025-6196(12)60766-6

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  3 in total

1.  Prospective comparison of radionuclide, computed tomographic, and sonographic localization of parathyroid tumors.

Authors:  A J Krubsack; S D Wilson; T L Lawson; B D Collier; R S Hellman; A T Isitman
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

2.  Clinical management of persistent and/or recurrent primary hyperparathyroidism.

Authors:  C S Grant; J A van Heerden; J W Charboneau; E M James; C C Reading
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

3.  PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor.

Authors:  Alexandre Loupy; Suresh Krishna Ramakrishnan; Bharath Wootla; Régine Chambrey; Renaud de la Faille; Soline Bourgeois; Patrick Bruneval; Chantal Mandet; Erik Ilso Christensen; Hélène Faure; Lydie Cheval; Kamel Laghmani; Corinne Collet; Dominique Eladari; Robert H Dodd; Martial Ruat; Pascal Houillier
Journal:  J Clin Invest       Date:  2012-08-13       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.